Literature DB >> 18676821

The Arf/p53 pathway in cancer and aging.

Ander Matheu1, Antonio Maraver, Manuel Serrano.   

Abstract

Arf and p53 are regarded among the most relevant tumor suppressors based on their ubiquitous and frequent inactivation in human cancer. The Arf/p53 pathway protects cells against several types of damage and this is the basis of its tumor suppressor activity. Interestingly, aging is a process associated with the accumulation of damage derived from chronic stresses of small magnitude. In agreement with its damage protection role, it has been recently described that the Arf/p53 pathway not only protects mammalian organisms from cancer but also from aging. However, there is also evidence that p53, under certain circumstances, such as when constitutively active, can induce aging. We discuss here the current evidence linking the Arf/p53 pathway to the process of aging and present a unified model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676821     DOI: 10.1158/0008-5472.CAN-07-6851

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  Using mice to examine p53 functions in cancer, aging, and longevity.

Authors:  Lawrence A Donehower
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11-04       Impact factor: 10.005

Review 2.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

Review 3.  p53 at a glance.

Authors:  Colleen A Brady; Laura D Attardi
Journal:  J Cell Sci       Date:  2010-08-01       Impact factor: 5.285

Review 4.  Linking functional decline of telomeres, mitochondria and stem cells during ageing.

Authors:  Ergün Sahin; Ronald A Depinho
Journal:  Nature       Date:  2010-03-25       Impact factor: 49.962

Review 5.  Development of cancer-initiating cells and immortalized cells with genomic instability.

Authors:  Ken-Ichi Yoshioka; Yuko Atsumi; Hitoshi Nakagama; Hirobumi Teraoka
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 6.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

7.  Tissue- and age-dependent expression of RNA-binding proteins that influence mRNA turnover and translation.

Authors:  Kiyoshi Masuda; Bernard Marasa; Jennifer L Martindale; Marc K Halushka; Myriam Gorospe
Journal:  Aging (Albany NY)       Date:  2009-07-26       Impact factor: 5.682

8.  The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway.

Authors:  Nicola J Maclaine; Ted R Hupp
Journal:  Aging (Albany NY)       Date:  2009-05-07       Impact factor: 5.682

9.  SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53.

Authors:  Cian J Lynch; Zahid H Shah; Simon J Allison; Shafiq U Ahmed; Jack Ford; Lorna J Warnock; Han Li; Manuel Serrano; Jo Milner
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

10.  Network strategies to understand the aging process and help age-related drug design.

Authors:  Gábor I Simkó; Dávid Gyurkó; Dániel V Veres; Tibor Nánási; Peter Csermely
Journal:  Genome Med       Date:  2009-09-28       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.